AzimianZavareh V, Rafiee L, Sheikholeslam M, Shariati L, Vaseghi G, Savoji H et al (2022) Three-dimensional in vitro models: a promising tool to scale-up breast cancer research. ACS Biomater Sci Eng 8(11):4648–4672

Article  CAS  Google Scholar 

Bi J, Newtson AM, Zhang Y, Devor EJ, Samuelson MI, Thiel KW et al (2021) Successful patient-derived organoid culture of gynecologic cancers for disease modeling and drug sensitivity testing. Cancers (Basel) 13(12):2901

Article  CAS  PubMed  Google Scholar 

Cao K, Zhang G, Zhang X, Yang M, Wang Y, He M et al (2021) Stromal infiltrating mast cells identify immunoevasive subtype high-grade serous ovarian cancer with poor prognosis and inferior immunotherapeutic response. Oncoimmunology 10(1):1969075

Article  PubMed  PubMed Central  Google Scholar 

Chang YH, Wu KC, Harnod T, Ding DC (2022) The organoid: a research model for ovarian cancer. Tzu Chi Med J 34(3):255–260

Article  PubMed  Google Scholar 

Chen H, Gotimer K, De Souza C, Tepper CG, Karnezis AN, Leiserowitz GS et al (2020) Short-term organoid culture for drug sensitivity testing of high-grade serous carcinoma. Gynecol Oncol 157(3):783–792

Article  CAS  PubMed  PubMed Central  Google Scholar 

Chen W, Fang PH, Zheng B, Liang Y, Mao Y, Jiang X et al (2023) Effective treatment for recurrent ovarian cancer guided by drug sensitivity from ascites-derived organoid: a case report. Int J Womens Health 15:1047–1057

Article  PubMed  PubMed Central  Google Scholar 

Clevers H (2016) Modeling development and disease with organoids. Cell 165(7):1586–1597

Article  CAS  PubMed  Google Scholar 

Colombo N, Sessa C, du Bois A, Ledermann J, McCluggage WG, McNeish I et al (2019) ESMO-ESGO consensus conference recommendations on ovarian cancer: pathology and molecular biology, early and advanced stages, borderline tumours and recurrent disease†. Ann Oncol 30(5):672–705

Article  CAS  PubMed  Google Scholar 

Cui Y, Xiao R, Zhou Y, Liu J, Wang Y, Yang X et al (2022) Establishment of organoid models based on a nested array chip for fast and reproducible drug testing in colorectal cancer therapy. Bio-Des Manuf 5(4):674–686

Article  Google Scholar 

Dai Y, Xu J, Gong X, Wei J, Gao Y, Chai R et al (2024) Human fallopian tube-derived organoids with TP53 and RAD51D mutations recapitulate an early stage high-grade serous ovarian cancer phenotype in vitro. Int J Mol Sci 25(2):886

Article  CAS  PubMed  PubMed Central  Google Scholar 

de Witte CJ, Espejo Valle-Inclan J, Hami N, Lõhmussaar K, Kopper O, Vreuls CPH et al (2020) Patient-derived ovarian cancer organoids mimic clinical response and exhibit heterogeneous inter- and intrapatient drug responses. Cell Rep 31(11):107762

Article  PubMed  Google Scholar 

Dijkstra KK, Cattaneo CM, Weeber F, Chalabi M, van de Haar J, Fanchi LF et al (2018) Generation of tumor-reactive T cells by co-culture of peripheral blood lymphocytes and tumor organoids. Cell 174(6):1586-1598.e12

Article  CAS  PubMed  PubMed Central  Google Scholar 

Drost J, van Jaarsveld RH, Ponsioen B, Zimberlin C, van Boxtel R, Buijs A et al (2015) Sequential cancer mutations in cultured human intestinal stem cells. Nature 521(7550):43–47

Article  ADS  CAS  PubMed  Google Scholar 

Drost J, Karthaus WR, Gao D, Driehuis E, Sawyers CL, Chen Y et al (2016) Organoid culture systems for prostate epithelial and cancer tissue. Nat Protoc 11(2):347–358

Article  CAS  PubMed  PubMed Central  Google Scholar 

Dumont S, Jan Z, Heremans R, Van Gorp T, Vergote I, Timmerman D (2019) Organoids of epithelial ovarian cancer as an emerging preclinical in vitro tool: a review. J Ovarian Res 12(1):105

Article  PubMed  PubMed Central  Google Scholar 

Fan H, Demirci U, Chen P (2019) Emerging organoid models: leaping forward in cancer research. J Hematol Oncol 12(1):142

Article  CAS  PubMed  PubMed Central  Google Scholar 

Gao D, Vela I, Sboner A, Iaquinta PJ, Karthaus WR, Gopalan A et al (2014) Organoid cultures derived from patients with advanced prostate cancer. Cell 159(1):176–187

Article  CAS  PubMed  PubMed Central  Google Scholar 

Gorski JW, Zhang Z, McCorkle JR, DeJohn JM, Wang C, Miller RW et al (2021) Utilizing patient-derived epithelial ovarian cancer tumor organoids to predict carboplatin resistance. Biomedicines 9(8):1021

Article  PubMed  PubMed Central  Google Scholar 

Granchi C, Bononi G, Ferrisi R, Gori E, Mantini G, Glasmacher S et al (2021) Design, synthesis and biological evaluation of second-generation benzoylpiperidine derivatives as reversible monoacylglycerol lipase (MAGL) inhibitors. Eur J Med Chem 209:112857

Article  CAS  PubMed  Google Scholar 

Gray HJ, Chatterjee P, Rosati R, Appleyard LR, Durenberger GJ, Diaz RL et al (2023) Extraordinary clinical response to ibrutinib in low-grade ovarian cancer guided by organoid drug testing. NPJ Precis Oncol 7(1):45

Article  CAS  PubMed  PubMed Central  Google Scholar 

Hamanishi J, Mandai M, Ikeda T, Minami M, Kawaguchi A, Murayama T et al (2015) Safety and antitumor activity of anti-PD-1 antibody, nivolumab, in patients with platinum-resistant ovarian cancer. J Clin Oncol 33(34):4015–4022

Article  CAS  PubMed  Google Scholar 

Han SJ, Kwon S, Kim KS (2021) Challenges of applying multicellular tumor spheroids in preclinical phase. Cancer Cell Int 21(1):152

Article  PubMed  PubMed Central  Google Scholar 

Haque MR, Rempert TH, Al-Hilal TA, Wang C, Bhushan A, Bishehsari F (2021) Organ-chip models: opportunities for precision medicine in pancreatic cancer. Cancers (Basel) 13(17):4487

Article  CAS  PubMed  PubMed Central  Google Scholar 

Hill SJ, Decker B, Roberts EA, Horowitz NS, Muto MG, Worley MJ et al (2018) Prediction of DNA repair inhibitor response in short-term patient-derived ovarian cancer organoids. Cancer Discov 8(11):1404–1421

Article  CAS  PubMed  PubMed Central  Google Scholar 

Hirt CK, Booij TH, Grob L, Simmler P, Toussaint NC, Keller D et al (2022) Drug screening and genome editing in human pancreatic cancer organoids identifies drug-gene interactions and candidates for off-label treatment. Cell Genom 2(2):100095

Article  CAS  PubMed  PubMed Central  Google Scholar 

Hoffmann K, Berger H, Kulbe H, Thillainadarasan S, Mollenkopf HJ, Zemojtel T et al (2020) Stable expansion of high-grade serous ovarian cancer organoids requires a low-Wnt environment. EMBO J 39(6):e104013

Article  CAS  PubMed  PubMed Central  Google Scholar 

Hu H, Gehart H, Artegiani B, Löpez-Iglesias C, Dekkers F, Basak O et al (2018) Long-term expansion of functional mouse and human hepatocytes as 3D organoids. Cell 175(6):1591-1606.e19

Article  CAS  PubMed  Google Scholar 

Hu Y, Sui X, Song F, Li Y, Li K, Chen Z et al (2021) Lung cancer organoids analyzed on microwell arrays predict drug responses of patients within a week. Nat Commun 12(1):2581

Article  ADS  CAS  PubMed  PubMed Central  Google Scholar 

Huang L, Holtzinger A, Jagan I, BeGora M, Lohse I, Ngai N et al (2015) Ductal pancreatic cancer modeling and drug screening using human pluripotent stem cell- and patient-derived tumor organoids. Nat Med 21(11):1364–1371

Article  CAS  PubMed  PubMed Central  Google Scholar 

Hughes CS, Postovit LM, Lajoie GA (2010) Matrigel: a complex protein mixture required for optimal growth of cell culture. Proteomics 10(9):1886–1890

Article  CAS  PubMed  Google Scholar 

Jabs J, Zickgraf FM, Park J, Wagner S, Jiang X, Jechow K et al (2017) Screening drug effects in patient-derived cancer cells links organoid responses to genome alterations. Mol Syst Biol 13(11):955

Article  PubMed  PubMed Central  Google Scholar 

Kandalaft LE, DangajLaniti D, Coukos G (2022) Immunobiology of high-grade serous ovarian cancer: lessons for clinical translation. Nat Rev Cancer 22(11):640–656

Article  CAS  PubMed  Google Scholar 

Kessler M, Hoffmann K, Brinkmann V, Thieck O, Jackisch S, Toelle B et al (2015) The Notch and Wnt pathways regulate stemness and differentiation in human fallopian tube organoids. Nat Commun 6:8989

Article  ADS  CAS  PubMed  Google Scholar 

Kim M, Mun H, Sung CO, Cho EJ, Jeon HJ, Chun SM et al (2019) Patient-derived lung cancer organoids as in vitro cancer models for therapeutic screening. Nat Commun 10(1):3991

Article  ADS  PubMed  PubMed Central  Google Scholar